Cite Filings / PLX / 0001558370-22-001858

Feed Companies Filings Check

Sign in

8-K

Current Report

Protalix BioTherapeutics, Inc. Filed 2022-02-24 Acc 0001558370-22-001858

Other events

Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

8-K Current Report , plx-20220224x8k.htm

Around this filing

2022-03-31 8-K Results of operations
2022-02-28 4 Sr. VP and CFO acquired 121,951 shares (grant or award)
2022-02-28 4 President and CEO acquired 637,531 shares (grant or award)
2022-02-24 8-K Other events
2021-12-22 8-K Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading plx-20220224x8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…